Hemiplegia for stroke in recovery stage
Conditions
Interventions
Sponsors
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Age
35 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) aged from 30 to 75 years; (2) meet the diagnostic criteria of cerebral infarction or cerebral hemorrhage in western medicine; (3) meet the diagnostic criteria and staging criteria of stroke in traditional Chinese medicine; (4) cerebral infarction or cerebral hemorrhage occurred within 3 months; (5) improved BARTHEL index score =3; (6) the patient and his/her family members voluntarily agree to participate in this clinical trial and sign the informed consent.
Exclusion criteria
Exclusion criteria: (1) lack of clear imaging evidence, such as CT or MRI, or lack of sufficient imaging evidence to determine the diagnosis; (2) stroke type: patients with progressive stroke and cerebral hemorrhage after cerebral infarction.Patients with impaired consciousness; (3) patients with mild illness;For patients with mild cerebral stroke or neurological impairment, the score of modified BARTHEL index was >=70.Non-disabling or rapidly improving patients with small strokes, including transient ischemic attack (TIA), reversible ischemic attack (RIND), etc.; (4) patients with acute stage vascular opening (such as thrombolysis, arterial thrombectomy, super-early thrombus aspiration and stenting, etc.); (5) those with bleeding tendency; Severe bleeding occurred within 3 months; (6) patients with severe cardiac insufficiency, patients with atrial fibrillation, patients with cardiac valvular disease or patients after cardiac valve replacement; (7) patients with other diseases that affect limb movement function, and patients with limb movement dysfunction caused by claudication, rheumatoid arthritis and gouty arthritis before treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Fugl-Meyer Assessment (FMA);Activies of Daily Living (ADL);Resting state functional MRI (rs-fMRI); | — |
Secondary
| Measure | Time frame |
|---|---|
| periinfarct microtubule-associated proteins gene (MAP-2);Western aphasia scale;Montreal Cognitive Assessment;TCM syndrome score;Water swallow test;Brain fuctional remodeling associated protein-43(GAP-43); | — |
Countries
China
Contacts
Public ContactPengqin Wang
Outcome results
None listed